Company Overview
Snapshot
Founded in January 2008 by Ronnie Klein and Yaniv Cohen, PIMS operated with 1–10 employees. The company holds one patent and was in the Pre-Funding stage, focusing on developing infrared-based endoscopy products.
Business overview
PIMS develops infrared-based endoscopy products for the early detection and diagnosis of colorectal cancer, gastric cancer, and other gastrointestinal tract diseases. Its core product is a patented, add-on imaging camera that uses an infrared detector to improve the detection of GI tract lesions. The device provides an additional field of view in the infrared range, visualizing irregular tissue that radiates differently from normal tissue, allowing for immediate spectrographic infrared signature analysis for early diagnosis. PIMS operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Diagnostics Devices, targeting healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is PIMS's primary focus?
- PIMS focuses on developing infrared-based endoscopy products for the early detection and diagnosis of colorectal cancer, gastric cancer, and other diseases of the GI tract.
- When was PIMS founded?
- PIMS was founded in January 2008.
- Who are the founders of PIMS?
- Ronnie Klein and Yaniv Cohen are the co-founders of PIMS.
- What is the status of PIMS?
- PIMS is currently non-active, having ceased to operate in August 2015.
- What technology does PIMS utilize in its products?
- PIMS utilizes infrared-based endoscopy technology, specifically an infrared detector device, to visualize and analyze irregular tissue in the GI tract.